YC Woo

[Amalie Xi Xiong @AmalieXiong_HKU]

Our study demonstrated increased risk of major osteoporotic #fractures after SARS-CoV-2 infection in both acute and post-acute phases in older adults, partly due to increased fall risk 🇭🇰@The_JBMR

👉🏻: https://t.co/bzSERGjR84

@DavidLui_HKU @CarlosWongHKU @Ian_HKU #LongCovid

[Michael Chan @MichaelCham10]

@DavidLui_HKU @NatureRevEndo @leechihopaul @woo_yc @IvanHung2 @hkumed @hkudeptmedicine Congrats !

[David Lui 呂德威 @DavidLui_HKU]

Excited for our final year MBBS student Darius & upcoming QMH Med resident Kimberly who presented their work on AFF & obesity Mx, respectively, in HKSEMR Annual Scientific Meeting. Congrats to Darius for winning Best Oral Presentation! 👏🏽👏🏽
@hkumed @hkudeptmedicine @woo_yc

[David Lui 呂德威 @DavidLui_HKU]

🎉 Delighted to share the 13-year experience of bisphosphonate-related atypical femoral #fractures 💊🦴 in our #Osteoporosis Centre @hkumed @hkudeptmedicine

Great collaborations with friends from @HkuPharm & @HKUOrtho ! 🤝

Find out more in 👉🏼 https://t.co/MNPuWnreRa

[JAMA Network Open @JAMANetworkOpen]

Use of molnupiravir or nirmatrelvir/ritonavir was associated with lower mortality and hospitalization for patients with #COVID19 and type 2 diabetes. https://t.co/1FbxJZy376 @hkumed @hkupharm @hku_d24h @hku_fmpc @CarlosWongHKU @DavidLui_HKU @woo_yc @leechihopaul @bencowling88

[David Lui 呂德威 @DavidLui_HKU]

Oral #COVID-19 Antivirals in Nonhospitalized Pts With T2 #Diabetes

🇭🇰 n=22,098
😷 Type 2 diabetes with COVID🦠
💊 Molnupiravir & nirmatrelvir-ritonavir ⚖️ vs non-users

✅ ⬇️29% risk of 🏥/⚰️

🔥Now in @JAMANetworkOpen!
https://t.co/6rvthYXYe0

@CarlosWongHKU @woo_yc

[PeerJ - Journal @PeerJSTM]

Fung et al. @HKUniversity present a prospective follow-up of thyroid volume and thyroiditis features on ultrasonography among survivors of predominantly mild to moderate COVID-19

Full article https://t.co/0MSuY5bdUk

#Diabetes #Endocrinology #Epidemiology #InfectiousDiseases

[David Lui 呂德威 @DavidLui_HKU]

This pretty much sums up our work on #COVID & #Thyroid! 🏁
Thx to all who've guided & supported me thru the journey! 🙏
@leechihopaul @woo_yc @kelvinkwto @IvanHung2 @CarlosWongHKU @Ian_HKU @FungMatrix @BrianHLang1 @hkumed @HkuPharm
🔥Link to the papers: https://t.co/5A6JFHS0vO

[David Lui 呂德威 @DavidLui_HKU]

🔥 Article in press! 🔥
Our 🇭🇰 population-based study showed no increase ↔️ in 🦴 #fracture risk with #SGLT2i use vs #DPP4i among type 2 #diabetes patients - across eGFR and albuminuria categories.
@CarlosWongHKU @leechihopaul @woo_yc @hkumed @HkuPharm
https://t.co/45ye3Cz1NS

[David Lui 呂德威 @DavidLui_HKU]

[Thyroid & COVID]

From our 6 month FU of 250 COVID survivors:
- Most abn TFTs in acute COVID resolved
- No sig incident thyroid dysfunction
- COVID didn’t lead to change in thyroid autoimmunity
- Thyroid function & Ab didn’t play a sig role in long COVID

https://t.co/PdJPf9G23y

[David Lui 呂德威 @DavidLui_HKU]

Case reports of thyrotoxicosis🔥 after COVID vax 💉 keep popping up… What’s the true size of the problem w/ mRNA & inactivated vax❓
Our 🇭🇰 population-based study showed no sig ⬆️ risk - ✅ reassure PPL to get 💉
Results just out in @BMCMedicine !
▶️ https://t.co/ZOVL2Lk2sF

[David Lui 呂德威 @DavidLui_HKU]

💊 DOAC vs warfarin for AF in PPL w/ type 2 diabetes❓
Better fracture risk profile in DOAC may be an additional edge over warfarin❗️🦴
📣 Results in @DiabetesCareADA 📖

@Tingting_WuHKU @leechihopaul @ChunKaWong @woo_yc @CarlosWongHKU @hkumed @HkuPharm

https://t.co/yEj0ATn3YW

[David Lui 呂德威 @DavidLui_HKU]

A special session dedicated to #COVID19 🦠 and #Endocrinology in EDMHK 2022 - updates on various aspects of COVID and diabetes/thyroid!
✍🏼 Register now by scanning QR code or clicking on the link https://t.co/tCHd7nielU ! 🔥
@hkumed @CUHKMedicine
#endotwitter #EDMHK2022

[David Lui 呂德威 @DavidLui_HKU]

⏰ Time to revisit the management of congenital adrenal hyperplasia and polycystic ovary syndrome in our daily endocrine practice! 📖
✅ Register for the EDMHK to listen to talks delivered by our paediatrician Dr Gloria Pang and gynaecologist Dr Raymond Li!
@hkumed

[David Lui 呂德威 @DavidLui_HKU]

❓Do you really know well antiresorptive-related atypical fractures?
❓How do you practically approach hypo-/hyper-calcaemia?
Dr YC Woo @woo_yc & Dr Joanne Lam @hkumed will share their insights‼️
⚠️ Don’t miss out, register at https://t.co/tCHd7nielU , or scan the QR code below

[David Lui 呂德威 @DavidLui_HKU]

🤔 USG report of fatty liver - what to do?
🤔 Hypothyroid pts asking for T3 replacement - your advice?

We are pleased to have endocrinologists Dr @leechihopaul and Alan Lee to share with us their insights in EDMHK 2022!

🚨Don’t miss out! Register now!

@hkumed
#Endotwitter

[David Lui 呂德威 @DavidLui_HKU]

Headaches when facing reports of thyroid nodules? How do we approach pituitary adenoma?
EDMHK 2022 will cover latest knowledge on Ax and Mx of thyroid nodule & pituitary adenoma 🚨
📣 Don’t miss out! Register now at https://t.co/r4CNnMDbju… ! Limited free quota a/v - DM me ☺️

[David Lui 呂德威 @DavidLui_HKU]

🚨 Our annual @hkumed endocrine conference EDMHK 2022 features 2 interesting plenary lectures - new horizons in Graves’ disease Mx, and bone fragility in diabetes! 🚨
📣 Don’t miss out! Save the date & register now at https://t.co/tCHd7nielU ! Limited free quota a/v - DM me ☺️

[David Lui 呂德威 @DavidLui_HKU]

Delighted to announce our 5th annual endocrinology conference EDMHK @hkumed to be held in Oct 2022! 🎊🎊 Covering various topics in #diabetes, #thyroid, #osteoporosis, electrolytes and #COVID19.
Register now! ✅
Check it out here ➡️ https://t.co/tCHd7nielU

[David Lui 呂德威 @DavidLui_HKU]

📣📣International Symposium on Healthy Aging 2022 will be on 13-14 Aug (VIRTUAL)! Exciting program covering latest updates for physicians & general practitioners in Mx cardiorenal-metabolic Dx etc in elderly. CME accredited! @hkumed
Register here:
https://t.co/arJyndVen2